Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus

被引:26
作者
Limal, N. [1 ]
Cacoub, P. [1 ]
Sene, D. [1 ]
Guichard, I. [1 ]
Piette, J-C [1 ]
机构
[1] Univ Paris 06, AP HP, Serv Med Interne, Hop La Pitie Salpetriere, F-75013 Paris, France
关键词
D O I
10.1177/0961203307083479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:69 / 71
页数:3
相关论文
共 5 条
[1]   Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: Distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome [J].
Dold, S ;
Singh, R ;
Sarwar, H ;
Menon, Y ;
Candia, L ;
Espinoza, LR .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :982-985
[2]   Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases [J].
Fakhouri, F ;
Vernant, JP ;
Veyradier, A ;
Wolf, M ;
Kaplanski, G ;
Binaut, R ;
Rieger, M ;
Scheiflinger, F ;
Poullin, P ;
Deroure, B ;
Delarue, R ;
Lesavre, P ;
Vanhille, P ;
Hermine, O ;
Remuzzi, G ;
Grünfeld, JP .
BLOOD, 2005, 106 (06) :1932-1937
[3]   The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders [J].
Franchini, Massimo ;
Veneri, Dino ;
Lippi, Giuseppe ;
Stenner, Rachel .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (02) :119-125
[4]   Rituximab therapy for refractory thrombotic thrombocytopenic purpura [J].
Gutterman, LA ;
Kloster, B ;
Tsai, HM .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (03) :385-391
[5]   Mechanisms of disease - Thrombotic microangiopathies [J].
Moake, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (08) :589-600